(Q34191186)

English

T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells (English)

1 reference

Europe PubMed Central

31 July 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Madhav V Dhodapkar

1

1 reference

Europe PubMed Central

31 July 2017

Joseph Krasovsky

2

1 reference

Europe PubMed Central

31 July 2017

Kara Olson

3

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

16 September 2002

1 reference

Europe PubMed Central

31 July 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

31 July 2017

99

1 reference

Europe PubMed Central

31 July 2017

13009-13013

1 reference

Europe PubMed Central

31 July 2017

20

1 reference

Europe PubMed Central

31 July 2017

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

Dendritic cells as vectors for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

Cross-presentation, dendritic cells, tolerance and immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

Dendritic cells in cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

The makings of a tumor rejection antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=130577

28 July 2018

Immune regulation in multiple myeloma: the host-tumour conflict

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202491499

21 January 2018

Active immunization against cancer with dendritic cells: the near future

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202491499

21 January 2018

Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202491499

21 January 2018

Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202491499

21 January 2018

Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202491499

21 January 2018

Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202491499

21 January 2018

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202491499

21 January 2018

Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202491499

21 January 2018

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202491499

21 January 2018

Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.202491499

21 January 2018

Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12235374

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12235374

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genes encoding tumor-specific antigens are expressed in human myeloma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12235374

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.202491499

1 reference

Europe PubMed Central

31 July 2017

2002PNAS...9913009D

0 references

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34191186&oldid=1964011306"